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Purpose: To determine the pattern of antihypertensive medication prescription in a referral hospital in 
Nigeria and its use by patients.   
Methods: By method of convenience sampling, 4954 prescriptions were collected from 376 files of 
hypertensive patients (> 18 years) visiting a referral hospital in Enugu, southeastern Nigeria between 
June and July 2009, were retrospectively surveyed. Data on visits, antihypertensive medication, non-
antihypertensive medication and drug adverse effects were extracted, coded and analyzed.  
Results: The mean age of hypertensive patients was 61 years, and an almost equal number of females 
(49 %) and males (51 %) visited the hospital. The average number of antihypertensive drug per patient 
was 2.63 ± 0.92 and 90 % of the patients were prescribed more than one drug in their last visit. For 
individual antihypertensive drugs, hydrochlorothiazide (29.7 %) and lisinopril (20.3 %) were the most 
prescribed with low-dose aspirin (39.7 %) and non-steroidal anti-inflammatory agents (16.7 %) occurring 
as most co-prescribed medication. Adverse effects were reported by 11 % of the patients while 18 % of 
the patients were non-adherent.  
Conclusion: The study showed a high use of more than one drug as supported by applicable guidelines 
hypertension, with diuretics and angiotensin converting enzyme inhibitors ACEIs the being most 
prescribed probably due to their low-cost and observed efficacy in this setting.     
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INTRODUCTION 
 
Hypertension is a frequently encountered 
chronic medical condition and is one of the 
most significant risk factors for cardiovascular 
morbidity and mortality. Developing 
economies struggle to maintain a qualitative 
health care sector and usually find it difficult 
keeping up with international standards of 
medical care. Hypertension management is 
for life and antihypertensive medications are 
relatively expensive. A report of the Joint 
National Committee on Prevention, 
Detection, Evaluation, and Treatment of High 
Blood Pressure was released in 2003 and 
was considered a gold standard for 
hypertension management [1]. The report 
among other things, advocates that a majority 
of patients will require two medications to 
reach goal blood pressure and thiazides for 
most of the stage 1 hypertension [1]. In the 
treatment of hypertension, however, an 
individualized stepped care therapy has been 
advocated for specific patients on the basis of 
differences in race, age, co-morbidity, 
adverse effects, adherence to treatment, etc, 
to improve cardiovascular outcomes [2]. 
Some studies support the use of calcium 
channel blockers and diuretics in the elderly 
and blacks and angiotensin converting 
enzyme inhibitors (ACEIs) and beta blockers 
in the young and Caucasians [3]. 
Combination therapy using antihypertensive 
drugs of different mechanisms of action has 
been used to produce optimal control of 
blood pressure where monotherapy fails [1].  
Various studies have been carried out on the 
utilization of antihypertensives in different 
regions of Nigeria [4,5]. However little or no 
information is available on antihypertensive 
usage in southeastern region of Nigeria, 
which is a densely populated part of the 
country. This study was aimed at evaluating 
the pattern of antihypertensive drug 
prescribing in a referral hospital in the 





This was a descriptive retrospective survey, 
cross-sectional in nature and carried out 
between the months of June and July 2009. 
The cardiovascular (medical) outpatient clinic 
of the University of Nigeria Teaching Hospital 
in Enugu, Enugu State was used for the 
survey. The facility is owned and funded by 
the Federal Government of Nigeria, with over 
500 beds in 41 departments and clinics. It is 
a referral center (especially for cardiovascular 
diseases) for neighbouring states, especially 
in the southeastern  part of Nigeria. The 
hospital has a mission to provide quality 
training, research and specialist healthcare 
for its clients in a friendly environment, and 
particularly pursues excellence in 
cardiovascular care.   
 
A data collection form was developed to 
collect information from patient’s 
prescriptions. It was pre-tested prior to the 
start of the study, using 20 randomly selected 
files which were not included in the final 
study. Necessary adjustments were made to 
the form. Ethical clearance for the study was 
granted by the University of Nigeria Teaching 
Hospital Research Ethics Committee and 
patients’ information was kept confidential. 
Folder numbers of visiting patients who were 
diagnosed and/or treated for hypertension for 
at least six months were collected from the 
clinic registers. Also only files with referral 
notes or orders were selected in order to note 
the first visit of the patient to the hospital. 
However, due to a high incidence of missing 
and temporary files, a convenience sampling 
method was employed. Four hundred files 
were sampled and twenty four files were 
removed because of incompleteness in 
prescription and prescription information. 
Three hundred and seventy six (376) files 
were used and data on patients’ 
characteristics, other co-existing diseases, 
number of prescriptions, prescription details 
on antihypertensive and non-hypertensive 
medication, level of patient’s medication 
adherence and adverse drug effects as 
documented by physicians, were collected. 
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These data were coded into Microsoft Excel 
2007, crosschecked for consistency, then 
entered into Statistical Package for Social 
Sciences application (SPSS Inc, version 14, 
Chicago, USA) and analyzed using 
descriptive frequencies of mean and 
percentages. Patient characteristics and 
prescription details were compared using 
analysis of variance and χ2 test for continuous 
and categorical variables, respectively. 
Spearman’s rank correlation coefficient was 
used to measure correlations between 
variables, and independent predictors were 
identified with multiple linear regression. P 
values < 0.05 were considered statistically 




A total of 4954 prescriptions were collected 
from the 376 patients’ files that were 
conveniently sampled. Patient characteristics 
are displayed in Table 1.  
 
Table 1: Characteristics of hypertensive adults 
visiting a Nigerian referral hospital 
 
Characteristics N* % 
Age, mean (SD) 61 (11.8)  
Age range 18-90  
Age group   
   18-49 53 (14.1) 
   50-90 323 (85.9) 
Sex   
   Male 192 51.1 
   Female 184 48.9 
Marital Status   
   Married 338 89.89 
   Single 17 4.52 
   Widowed 21 5.59 
Occupation    
  Civil servant 80 21.27 
  House wife 91 24.20 
  Pensioner 21 5.58 
  Skilled worker 52 13.82 
  Unskilled worker 99 26.32 
  Retired  24 6.38 
  Unemployed 4 1.06 
  No records 5 1.33 
Total 376 100.00 
*N = number of patients; SD = standard deviation. 
 
Co-existing diseases and blood pressure 
levels during visit 
 
Of all the patients, 267 (71 %) were co-
diagnosed with one form of cardiovascular 
disease or chronic ailment. Diabetes ranked 
as the most frequent co-morbidity (n=77, 19.7 
%) followed by hypertensive heart disease (n 
= 56, 14.3 %), as indicated in Table 2. There 
were also a high number of patients who had 
suffered cerebrovascular accident (n=43, 11 
%) and peptic ulcer (n=57, 14.6 %). The 
average systolic (SBP) and diastolic blood 
pressures (DBP) of patients during first and 
last visits are shown in Table 2. The mean 
SBP/DBP in the first visit of patient was 163.0 
± 24.2/99.0 ± 15.8 mmHg (mean ± SD) and in 
the last visit was 141.0  ± 23.3/87.0 ±15.1 
mmHg (P < 0.05). Also displayed in Table 2, 
is the distribution of blood pressure levels 
among patients using the JNC 7 report [1]. 
From the first to the last visits, there was a 
significant change in the number of patients 
with normal blood pressure, prehypertension, 
stage 2 hypertension, and isolated diastolic 
hypertension (IDH).  
 
Class of hypertension by blood pressure 
measurement showed positive correlation 
with number of drugs in the last prescription 
(p < 0.001) but no correlations were seen 
with age, sex or number of comorbidities. 
Multiple regression showed that the only 
number of drugs in the last prescription 
(β=0.252, P=0.001) was an independent 
predictor of BP at the last visit (R = 0.284, p <  
0.001). 
 
Number of antihypertensive drugs 
 
From the collected prescriptions, a total of 
12,079 antihypertensive medications were 
prescribed to all the patients from their first 
visit to the study date. The frequency of 
antihypertensive agents prescribed to 
patients in their first and last visits before the 
study, are presented in Table 3. The average 
number of drugs prescribed per patient in the 
first  and  last  prescriptions  was  2.25 ± 0.77 
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Table 2: Patients’ blood pressure distribution (by 
class) and co-morbidities at the first and last visits 
of the study period 
 
Blood Pressure First visit Last visit 
Average (SD)    N (%)    N (%) 
Systolic BP (mmHg) 163 (14.2) 141 (23.3)* 
Diastolic BP (mmHg) 99 (15.8) 87 (15.1)* 
Class    
Normal 13 (3.50) 71 (18.90)* 
Prehypertension 42 (11.20) 145 (38.60)* 
Stage 1 46 (12.20) 43 (11.40) 
Stage 2 171 (45.50) 58 (15.40)* 
Isolated Systolic 
Hypertension 
46 (12.20) 43 (11.40) 
Isolated Diastolic 
Hypertension 
51 (13.60) 14 (3.70)* 
Nil record 7 (1.90) 2 (0.50)* 
Total 376 376 











Dyslipidemia 6 1.54 




Arthtritis 45 11.54 
Peptic ulcer  57 14.6 
Seizures 16 4.10 
Obesity 19 4.87 
Asthma 13 3.33 
Others 28 7.15 
Total  390 100 
BP values are shown as mean (SD); * represents 
changes at p < 0.05, one-way analysis of variance. N 
represents the number of patients with the particular 
disease or blood pressure class 
 
and 2.63 ± 0.93, respectively. There was a 
reduction in the number of patients on one 
drug between the first and the last visit (104 
to 35), and two drugs (184 to 144) but an 
increase in patients receiving three drugs (77 
to 130), four drugs (11 to 59) and five drugs 
(0 to 8). All these changes were significant at 
p < 0.001. Ninety percent (90 %) of patients 
were prescribed more than one drug in their 
last visit. Correlation results show positive 
correlations and predictor ability of average 
number of drugs (R = 0.783, p < 0.001) taken 
by the patients with class of age (β = 0.232, p 
= 0.001) and maximum number (β = 0.565, p 
< 0.001) of drugs taken in a single 
prescription. 
 
Commonly used antihypertensive drugs 
 
Table 3 presents the number of patients that 
were prescribed specific antihypertensive 
drugs at the first and last visits; there was a 
high rate of use of hydrochlorothiazide (27.7 
and 29.7 %, respectively), lisinopril (14.2 and 
20.3 %, respectively) and nifedipine (12.3 
and 11.3 %, respectively). There was a high 
use rate of benzodiazepines for the treatment 
of hypertension only at the first visit (2.7 %).  
 
Use by class (Figure 1) shows a high use 
rate  of diuretics at the first and last visits 
(48.2 and 46.4 %, respectively), 
ACEIs/angiotensin receptor blockers (ARBs) 
(18.2 and 25.6 %, respectively) and calcium 
channel blockers (CCBs) (15.1 and 15.9 %, 
respectively) with the use of ACEI/ARB 




Based on physicians’ documentation, a 
majority (268, i.e., 71 %) received non-
pharmacological counsel while the remaining 
(108, i.e., 29 %) did not. Specifically, salt 
restriction (n = 118, 31.3 %), diet therapy (n = 
76, 20.2 %) and weight reduction (n = 102, 
27.1%) were the most frequent nonpharma-
cological advice. Other documented counsel 
include physiotherapy (8.3 %) and stress 




About 40 % (n=147) of the patients were 
placed  on  low-dose  (75 mg)  aspirin  and 
about 11 (3 %) on statins. With about 19 % 
of the patients diabetic, only 30 (8 %) were 
on antidiabetics. Also, over 16 % (n=62) of  
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Table 3: Frequency of antihypertensive medication prescribed in the first and last prescriptions 
 
    First visit     Last visit  
Antihypertensive drug  N*   %   N*    % 
Diuretics   
Amiloride 98 11.54 73 7.38 
Hydrochlorothiazide 236 27.7 294 29.72 
Chlorthalidone  8 0.94 9 0.91 
Frusemide 37 4.35 36 3.64 
Spironolactone 30 3.53 43 4.34 
Calcium channel blockers  
Amlodipine  15 1.76 24 2.42 
Felodipine 8 0.94 17 1.71 
Nifedipine  105 12.36 117 11.38 
Beta blockers  
Propanolol  17 2.00 14 1.41 
Atenolol  9 1.06 11 1.11 
Metoprolol  - - 1 0.1 
Angiotensin converting enzyme inhibitors  
Lisinopril 121 14.25 201 20.32 
Enalapril 16 1.88 30 3.03 
Ramipril 16 1.88 13 1.31 
Captopril 1 0.11 - - 
Angiotensin receptor blockers  
Losartan  - - 5 0.5 
Valsartan 1 0.11 5 0.5 
Miscellaneous drugs  
Hydralazine 11 1.29 3 0.3 
Methyldopa 64 7.53 86 8.69 
Reserpine 29 3.41 2 0.2 
Prazocin 1 0.11 4 0.4 
Intravenous fluids 3 0.35 - - 
Benzodiazepine 23 2.71 1 0.1 
Total  849 100 989 100 
* N represents the number of patients prescribed the particular drug. Percentage was calculated per total of number 
drugs in that visit. 
 
Figure 1: Prescription of antihypertensive drugs by class to patients during their first and last visits. Note: 
CCB= Calcium Channel Blockers, ACEI/ARB=Angiotensin Converting Enzyme Inhibitors/Angiotensin 
Receptor Blockers, BB=Beta Blockers, MScl= Miscellaneous drugs) 
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the patients were on NSAIDs with only 41 
(11%) of them reported to be suffering from 
an arthritic condition. 
 
Adverse effects and adherence to 
medication 
 
In the patient files, physicians documented 
complaints of adverse effects and the 
implicating medications.  Among the patients, 
43 (11.4 %) complained of an adverse effect 
with cough (n = 25, 58 %), headache (n = 5, 
11.6 %) and rashes (n = 5, 11.6 %) 
constituting the most common ones. Lisinopril 
(n=25, 58 %) and nifedipine (n = 7, 16 %) 
were the drugs most implicated for causing 
the adverse effects. Of the 376 patients on 
antihypertensive agents, 70 (18 %) were 
recorded by their physicians to be poor or 
non-adherent to their medications. When an 
attempt was made to correlate medication 
adherence with patients’ characteristics, sex 
and blood pressure taken at last visit, showed 
statistically significant difference (at p = 0.009 
and p = 0.002) between the adherent and 
non-adherent groups. There were more 
females in the non-adherent group than in the 





This study examined the pattern of 
antihypertensive drug prescriptions in a 
tertiary hospital in Eastern Nigeria in order to 
obtain an insight into the current utilization of 
antihypertensive drugs. Some limitations of 
this study include the fact that the hospital 
used may not be representative of other 
hospitals in the southeastern region of 
Nigeria which are much smaller in size and 
lack the high calibre healthcare expertise 
available in the health facility used in the 
present study. Also due to the retrospective 
nature of this study, some clinical information 
(for example, on non-pharmacological advice 
and compliance) could not be retrieved from 
the physicians and patients and this may 
affect the validity of the adherence 
information obtained from patients’ files.  
It has been established that advancing age is 
a risk factor for cardiovascular risk diseases 
[1] and our sample had a larger proportion of 
older adults, an age group where the 
incidence of hypertension increases with age. 
Diabetes, hypertensive heart disease and 
cerebrovascular accident (CVA) were the 
most co-diagnosed diseases and their high 
incidence will alter treatment regimen and 
achievement of optimal blood pressure in 
these patients. The observation that more 
patients had one form of co-existing chronic 
disease is consistent with the fact that the 
higher systolic blood pressure (prevalent in 
this study sample) is associated with 
increased risk of cardiovascular diseases [1]. 
The high incidence of CVA in the 
prehypertensive class has been reported in 
the current JNC 7 report and could be 
attributed to non-awareness of this slightly 
abnormal blood pressure levels by most 
people and its tendency (i.e., non-awareness) 
to increase the progression of complications 
of hypertension. The increase in the number 
of antihypertensive drugs prescribed to 
patients at the last visit from the time of first 
visit may be a reflection of worsening of the 
high blood pressure condition, increase in the 
intensity of treatment or prescriber’s 
awareness of the benefits of the use of more 
drugs to improve management of the 
disease.  
 
The results from this study show that the use 
of combination therapy was higher than those 
recorded in similar studies conducted in 
southwestern and northern regions of Nigeria 
[6,7]. Older adults took more drugs than the 
younger group, a possible reflection of an 
urgent need by physicians to critically control 
blood pressure in this special group with 
higher systolic blood pressure values and risk 
for cardiovascular diseases. In the first visit, 
the use of hydrochlorothiazide and lisinopril 
was highest and could be attributed to the 
advocated use of hydrochlorothiazide both as 
a monotherapy and as an adjunct in 
antihypertensive combination therapy [1]. 
Diuretics are said to be superior to α-
blockers, CCBs, and ACEIs in preventing one 
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or more forms of CVDs, including stroke and 
heart failure [3] and its low cost gives it 
further advantage. The high use of lisinopril 
despite reported claims of its average 
efficacy among blacks and the elderly is 
probably due to its proven benefits in 
cardiovascular protection [8], and 
renoprotection [9]. Diuretics use (by class) 
was the highest in this study and may be 
attributed to its low cost, efficacy in blacks 
and synergistic effect when used in 
combination with other potent antihyper-
tensive agents [1]. ACEIs/ARBs also 
remained favorites for prescribers in this 
study due perhaps to their documented 
benefits in hypertensives suffering some 
other diseases (such as diabetes) and their 
increased efficacy in blacks when used in 
combination with diuretics [10]. A study in 
Ibadan, Nigeria [6] reported a lower use of 
ACEIs (8.6 %) in its cohorts and this marked 
difference with results in this study may be 
due to differences in prescriber 
characteristics. The prescribing of 
benzodiazepines alone to patients diagnosed 
as “hypertensive” has not been justified in 
reducing blood pressure in clinical 
hypertension [11]. A majority of the sedatives 
may have been prescribed as anxiolytics to 
calm anxious patients.  
 
Several studies have documented the long-
term benefits of the use of anti-hypertensive 
combinations in high-risk populations, such 
as blacks, who are usually at increased risk 
of morbidity and mortality from 
cerebrovascular and cardiovascular events 
[12]. Furthermore, black hypertensives have 
higher incidences of concurrent diseases 
such as left ventricular hypertrophy, 
congestive cardiac failure, diabetes mellitus 
and chronic renal failure and have been 
shown to benefit from the use of anti-
hypertensive drug combinations [6]. The most 
prescribed antihypertensive combination in 
this study was lisinopril+hydrochlrothaizide at 
both visits and it has been shown that 
addition of a low-dose diuretic to lisinopril can 
achieve blood pressure control in 80-90% of 
black patients [10]. 
 
The use of low-dose aspirin was high in this 
population and may provide some benefits for 
patients with cardiovascular complications. 
With less than half of diabetics placed on 
pharmacological treatment and a relative few 
on diet therapy, about half of them were 
untreated for diabetes. No reason could not 
be given for this untreated group of diabetics 
but high cost of antidiabetics may have been 
responsible. The high prescription rate of 
NSAIDs in these patients is worrisome, and 
the concomitant use of antiulcerogenic 
agents and antacids could have been 
responsible for NSAID- induced ulcers while 
on therapy. Statins been shown to have 
beneficial effects in secondary prevention of 
cardiovascular events and its use in this 
population interestingly was still low and 
inadequate. 
 
The combined high prescription  rate of 
exercise, reduction of fat intake and weight 
reduction may be attributed to a large number 
of obese and overweight patients, a reflection 
of results from other studies [14], and the 
well-known efficacy of salt restriction in 
reducing blood pressure in hypertensive 
patients, blacks in particularly [2].  
 
Over 11.0 % of patients complained of 
adverse effects and this finding is similar to 
those of earlier studies which reported a 
frequency of 11.0 and 10.9%, respectively 
[6,15] among hypertensive patients in a 
similar study setting. This may not be 
reflective of the true occurrence of adverse 
reactions in these patients, as poorly 
institutionalized adverse drug reaction 
reporting system limits proper documentation 
of adverse reactions in the health care 
setting.  Lisinopril caused most of these side 
effects and the irritating cough produced has 
been well documented as well as noted in 
some other works as a major reason for poor 
compliance and discontinuation of ACEIs 
[16]. These complaints of adverse effects by 
patients as documented by physicians may 
be lower than actual events and can only be 
effectively evaluated if a well-organized 
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adverse drug reaction monitoring system 
were in place in this setting.  
 
Medication adherence as recorded by 
patients’ physicians has been used reliably in 
another Nigerian study and the result 
obtained in this study is similar to those 
obtained in the southwestern Nigeria study 
which reported inadequate adherence in only 
17.5 % of its cohort [17]. More females did 
not adhere to their medications, but no 
concrete rationale could be raised concerning 
this as more females attained lower blood 
pressure than their male counterparts. 
However, women have been known to be at 
higher risk of ACEI-induced adverse effects 
than men and therefore may exhibit higher 




This study has shown that hypertension in 
this tertiary hospital is being treated with 
more than one drug in most patients 
especially in the elderly. Lisinopril and 
hydrochlorothiazide were most prescribed 
drugs and there is increasing trend of 
prescribing ACEIs, diuretics and fixed-dose 
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